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Background
In severe aortic stenosis (AS), hemodynamics and con-
ventional indices do not fully explain symptoms, prog-
nosis or treatment response. We hypothesize that
diffuse myocardial fibrosis (DMF) is a key missing factor
in AS. This can now be accurately measured non-inva-
sively using equilibrium contrast CMR (EQ-CMR) [1]
involving a primed gadolinium infusion, T1 measure-
ment pre- and post-infusion, and direct measure of
blood volume of distribution (1-hematocrit). The
derived myocardial volume of distribution (Vd(m)) corre-
lates strongly with histological diffuse myocardial
fibrosisin AS and this calibration can convert Vd(m) to
DMF%. Cell volume can be calculated as 1-DMF%*LV
mass.
Methods
63 severe AS patients with planned valve replacement
underwent baseline and follow up EQ-CMR. Twenty
normal controls were included. Baseline and follow-up
assessment included NYHA, ECG, echocardiography
(for diastolic function and valve area/velocities), BNP
and six minute walk test (6MWT). Follow up was at
6-months (2 declined, 4 late deaths, 13 pacemakers,
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Figure 1 Relationship of DMF with 6MWT and NYHA class.
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expressed as Vd(m)/DMF% (continuous variable or sever-
ity tertiles), or cell volume.
Results
Baseline
AS patients had more fibrosis than controls (Vd(m):0.27±
0.04 vs 0.24±0.04; DMF:17% vs 11%, p = 0.003) with a
wide range (Vd(m):0.20-0.39; DMF:4-42%). Breathless
patients had more DMF (NYHA class III/IV vs I/II: Vd
(m):0.32±0.03 vs 0.26±0.04; DMF:15% vs 27%, p<0.001).
DMF correlated with 6MWT (inversely, figure 1,
r
2=0.22, p=0.001) and aortic valve area (r
2=0.21,
p=0.001). DMF only correlated with EF in patients with
LV impairment (n=15, r
2=0.47, p=0.01). Severe DMF
patients had worse diastolic function (p=0.029). In a
multivariate analysis of all parameters classically asso-
ciated with 6MWT distance, the only independent pre-
dictor was DMF (p=0.04). On univariate analysis there
was a weak correlation with BNP and age.
Follow up
Overall, patients improved at follow-up (6MWT, EF,
BNP, LV mass, LV volumes). However, only patients
with severe fibrosis improved their exercise capacity
(p=0.03). LVH regression (202g vs 183g, p=0.002) was
shown to be cellular (161g vs. 142g, p<0.001) rather
than fibrosis (36g vs 34g p=0.572) resolution, figure 2.
Conclusion
In this first clinical EQ-CMR study of severe AS, DMF
is higher when there is LV impairment, diastolic dys-
function and more severe stenosis. DMF is the single
best predictor of pre-op exercise capacity and post-op
improvement. EQ-CMR shows that at 6-month post
valve replacement LVH regression is predominantly
reduced cell rather than fibrosis volume. EQ-CMR for
the non-invasive measurement of DMF appears to be a
significant cardiological advance.
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Figure 2 LVH regression redefined by EQ-CMR.
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